Rhea-AI Summary
Analysis in progress…
Loading…
Loading translation…
-45.63%
Since News
$8.22
Last Price
$8.17
$15.50
Day Range
-$1.94B
Valuation Impact
$2.31B
Market Cap
0.6x
Rel. Volume
Following this news, POET has declined 45.63%, reflecting a significant negative market reaction.
Our momentum scanner has triggered 91 alerts so far, indicating high trading interest and price volatility.
The stock is currently trading at $8.22.
This price movement has removed approximately $1.94B from the company’s valuation.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Alternate purchase order
$5 million
Recently disclosed purchase order with another technology company
$15.10
Last Close
Volume
Volume 77,045,480 is 3.18x the 20-day average of 24,211,888, indicating elevated trading activity ahead of this update.
high
Technical
Price at 15.10 is trading above the 200-day MA of 6.33 and sits 2.58% below the 52-week high of 15.50.
POET gained 28.84% with strong volume, while peers showed mixed moves: some like AIP were up, others like SKYT and IMOS were down. This combination points more to POET-specific dynamics than a clean sector-wide move.
Date
Event
Sentiment
Move
Catalyst
Apr 14
Tax status update
Positive
+3.9%
Clarified PFIC status and QEF election details plus potential U.S. redomicile.
Mar 31
Earnings and funding
Negative
-5.7%
Reported Q4 2025 net loss and highlighted large equity financings and cash.
Mar 17
AI partnership
Positive
-4.9%
Announced 1.6T 2×DR4 optical transceiver JV targeting AI clusters and data centers.
Mar 16
AI collaboration
Positive
+0.7%
Strategic collaboration with LITEON to co-develop optical modules for AI.
Mar 10
Product showcase
Positive
+4.6%
OFC conference demos of Blazar and Starlight light-source products for AI.
Pattern Detected
News-related moves generally align with sentiment; most positive or clarifying updates saw modest gains, while dilutive or loss-heavy results weighed on shares, with one notable divergence on a positive partnership.
Recent Company History
Over recent months, POET has alternated between strategic partnership news and heavier financial disclosures. In Q4 2025 results on Mar 31, the company reported a net loss of $42.7M and modest revenue, alongside significant capital raises, and the stock fell. AI-focused collaborations with Lessengers and LITEON in mid-March highlighted growth ambitions but produced only small or negative reactions. PFIC and redomiciling clarity on Apr 14 saw a mild gain. Against this backdrop, the reported cancellation of Celestial AI purchase orders contrasts with the pre-news price strength and elevated interest in POET’s AI optics roadmap.
The stock is dropping -45.6% following this news. A negative reaction despite POET’s broader AI optics story would fit prior patterns where loss-heavy or structurally adverse news weighed on the stock. Earlier, the market responded poorly to the Q4 2025 loss and capital raises, while reacting modestly to partnerships. The cancellation of Celestial AI purchase orders could renew concerns about customer concentration and execution. With the stock previously trading near its 52-week high, expectations embedded in the price may have been vulnerable.
AI-generated analysis. Not financial advice.
04/27/2026 – 08:58 AM
SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced the cancellation of all purchase orders received by the Company from Celestial AI, including the ones for initial production units first disclosed (the “Purchase Orders”) by the Company in a press release on April 25, 2023. Marvell Semiconductor Inc., which acquired Celestial AI, provided written notice of the cancellation to the Company on April 23, 2026. As the basis for the cancellation, Marvell indicated that the Company had made disclosures of information related to the Purchase Order and shipping information in contravention of its confidentiality obligations.
The Company remains focused on executing its strategic priorities and advancing product development within the AI and optical networking markets to meet increasing demand. This effort also involves fulfilling product deliveries for other customers, including a recently disclosed purchase order with another technology company with a value of approximately $5 million.
About POET Technologies Inc.
POET Technologies is a design and development company offering high-speed optical engines, light source products, and custom optical modules for the artificial intelligence systems market and hyperscale data centers. Its patented POET Optical Interposer™ platform enables seamless chip-scale integration of photonic and electronic devices using advanced semiconductor manufacturing techniques. More information about POET is available on our website at www.poet-technologies.com.
Forward-Looking Statements
This news release contains “forward-looking information” (within the meaning of applicable Canadian securities laws) and “forward-looking statements” (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as “anticipate”, “believe”, “expect”, “plan”, “intend”, “potential”, “estimate”, “propose”, “project”, “outlook”, “foresee” or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements or information include the Company’s expectations regarding delivery of products under existing purchaser orders, demand for the Company’s products, the Company’s product development efforts, the performance of its products, the expected results of its operations, meeting revenue targets, and the expectation of continued success in financing efforts, the capability, functionality, performance and cost of the Company’s technology as well as the market acceptance, inclusion and timing of the Company’s technology in current and future products.
Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those expressed in or implied by such forward-looking statements or information.. Assumptions have been made regarding, among other things, future growth, recruitment of personnel, plans for and completion of projects by the Company’s consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures, and such assumptions may prove to be incorrect. Actual results could differ materially due to a number of factors, including, without limitation, any possible ability of the Company to re-establish its relationship with Marvell Semiconductors and to secure future product orders from Marvell; the ability of the Company to satisfy its obligations under existing purchase orders; the failure of its products to meet performance requirements; increases, decreases, cancellations or delays in purchase orders already in place without significant penalty to the counterparty; failure to receive future purchase orders; lack of sales in its products, once released; operational risks in the completion of the Company’s anticipated projects; risks affecting the Company’s ability to execute projects; the ability of the Company to generate sales for its products; the ability to attract key personnel; the ability to raise additional capital and other risks and uncertainties discussed in the Company’s filings on SEDAR+ and with the U.S. Securities and Exchange Commission, including under the caption “Risk Factors” in such filings. Prospective investors in the Company’s securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075.
